Central Executive Committee (PAP)

TREEFROG THERAPEUTICS REINFORCES EXECUTIVE COMMITTEE WITH THREE NEW MEMBERS

Retrieved on: 
Jeudi, novembre 9, 2023
University of Los Andes (Colombia), IPO, Biogen, Therapy, Tajikistan State University of Law, Business, & Politics, Tree, Doctor of Philosophy, MBA, Engineering, HEC Paris, Central Executive Committee (PAP), Politics, Growth, Trinity College, Medicine, Paris, Executive Committee, Business, Senior, University of Hamburg, Ethicon, University, Trinity College Dublin, Sanofi, International communication, La Jolla Institute for Immunology, Immunology, Management, Bayer, Merck

BORDEAUX, France, Nov. 9, 2023 /PRNewswire/ -- TreeFrog Therapeutics, a global biotechnology company advancing a pipeline of cell therapies based on a disruptive proprietary technology platform, today announced the appointment of three new members to the Executive Team.

Key Points: 
  • "Since our inception in 2018, TreeFrog has made great strides, and I am proud of the progress the teams have made in our therapeutic programs, technology and partnerships.
  • We are part of the revolution in medicine, pioneering therapeutics and technology in cell therapy.
  • Reinforcing the Executive Committee team is crucial for the next phase in our future growth," Frederic Desdouits, PhD, CEO of TreeFrog Therapeutics.
  • For further information on the Executive Committee, visit www.treefrog.fr

TREEFROG THERAPEUTICS REINFORCES EXECUTIVE COMMITTEE WITH THREE NEW MEMBERS

Retrieved on: 
Jeudi, novembre 9, 2023
University of Los Andes (Colombia), IPO, Biogen, Therapy, Tajikistan State University of Law, Business, & Politics, Tree, Doctor of Philosophy, MBA, Engineering, HEC Paris, Central Executive Committee (PAP), Politics, Growth, Trinity College, Medicine, Paris, Executive Committee, Business, Senior, University of Hamburg, Ethicon, University, Trinity College Dublin, Sanofi, International communication, La Jolla Institute for Immunology, Immunology, Management, Bayer, Merck

BORDEAUX, France, Nov. 9, 2023 /PRNewswire/ -- TreeFrog Therapeutics, a global biotechnology company advancing a pipeline of cell therapies based on a disruptive proprietary technology platform, today announced the appointment of three new members to the Executive Team.

Key Points: 
  • "Since our inception in 2018, TreeFrog has made great strides, and I am proud of the progress the teams have made in our therapeutic programs, technology and partnerships.
  • We are part of the revolution in medicine, pioneering therapeutics and technology in cell therapy.
  • Reinforcing the Executive Committee team is crucial for the next phase in our future growth," Frederic Desdouits, PhD, CEO of TreeFrog Therapeutics.
  • For further information on the Executive Committee, visit www.treefrog.fr

New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

Retrieved on: 
Jeudi, novembre 2, 2023
Research, FDA, Diabetes, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Science, Other Science, Plasma, Hyperkalemia, EGFR, Heart, Biomarker, Safety, Fibrosis, Kidney disease, Inflammation, Type 2 diabetes, Society, Chronic kidney disease, Phase, Central Executive Committee (PAP), ASN, Risk, T2D, Executive Committee, MOA, CKD, Hospital, Patient, Heart failure, Pharmaceutical industry, Bayer, Finerenone

2

Key Points: 
  • 2
    Kerendia is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with CKD associated with T2D.3 The Kerendia label contains a Warning and Precaution that Kerendia can cause hyperkalemia.
  • The data from FIGARO-BM, an exploratory human biomarker study, provide findings which support the mechanism of action of Kerendia in blocking MR overactivation, thought to contribute to inflammation and fibrosis.
  • Left untreated, inflammation and fibrosis can lead to damage in the kidneys and heart.
  • 3
    “The biomarker findings from FIGARO-BM are an important moment for Bayer,” said Dr. Christian Rommel, Member of the Executive Committee of Bayer AG's Pharmaceutical Division and Head of Research and Development.

SCOR appoints Claudia Dill and Redmond Murphy to the Executive Committee

Retrieved on: 
Mercredi, septembre 27, 2023
SCOR, Insurance, Statistics, Zurich Insurance Group, CFA, University, Actuarial science, Advanced Management Program, Life, University of St. Gallen, MBA, Commerzbank, L&H, Deutsche Bank, Credit Suisse, Self-help group (finance), Bachelor of Science, Wharton School of the University of Pennsylvania, Williams v Natural Life Health Foods Ltd, Master of Science, Executive Committee, Forward, Cooper, Business performance management, CFO, Central Executive Committee (PAP), University College Cork, Economics, Automation, Management, Mathematics, Paulo

Claudia Dill joins SCOR as Group Chief Operating Officer and member of the Executive Committee in charge of Technology, Transformation, Global Real Estate and Regional Services Platforms.

Key Points: 
  • Claudia Dill joins SCOR as Group Chief Operating Officer and member of the Executive Committee in charge of Technology, Transformation, Global Real Estate and Regional Services Platforms.
  • Redmond Murphy, previously Deputy Group Chief Financial Officer and Group Head of Business Performance, is appointed Deputy CEO of SCOR Life & Health and member of the Executive Committee.
  • Based in Dublin, Redmond Murphy will report to Frieder Knüpling, CEO of SCOR Life & Health.
  • Thierry Léger, Chief Executive Officer of SCOR, comments: “I am very pleased to welcome Claudia and Redmond to the Executive Committee.

National University Health System Launches World's First Public Hospital's Healthy Longevity Clinic at Alexandra Hospital

Retrieved on: 
Samedi, septembre 2, 2023
Medical school, Human, CHL, Education, Internal medicine, World Economic Forum, National University Health System, Longevity, Research, Biomarker, Alexandra Hospital, NUHS, Physician, Nursing, Executive Committee, Conditional sentence, Central Executive Committee (PAP), NUS, Medical imaging, Medicine

SINGAPORE, Sept. 2, 2023 /PRNewswire/ -- The National University Health System (NUHS), NUS Yong Loo Lin School of Medicine and Alexandra Hospital (AH ) have achieved a milestone by unveiling the world's inaugural Healthy Longevity Clinic by public healthcare.

Key Points: 
  • SINGAPORE, Sept. 2, 2023 /PRNewswire/ -- The National University Health System (NUHS), NUS Yong Loo Lin School of Medicine and Alexandra Hospital (AH ) have achieved a milestone by unveiling the world's inaugural Healthy Longevity Clinic by public healthcare.
  • Located at Singapore's Alexandra Hospital, the clinic aims to delay biological ageing, thereby optimising functionality and resilience and increasing health span through evidence-based diagnosis and intervention.
  • Using biomarkers of ageing that are specific to the Singapore population, the clinic will leverage breakthroughs from the NUHS research Centre for Healthy Longevity (CHL) and incorporate advances in geroscience and healthy longevity medicine towards precision medicine.
  • The Healthy Longevity Clinic endeavours to amplify the healthspan of Singaporeans by three years within the next decade.

National University Health System Launches World's First Public Hospital's Healthy Longevity Clinic at Alexandra Hospital

Retrieved on: 
Vendredi, septembre 1, 2023
Medical school, Human, CHL, Education, Internal medicine, World Economic Forum, National University Health System, Longevity, Research, Biomarker, Alexandra Hospital, NUHS, Physician, Nursing, Executive Committee, Conditional sentence, Central Executive Committee (PAP), NUS, Medical imaging, Medicine

SINGAPORE, Sept. 1, 2023 /PRNewswire/ -- The National University Health System (NUHS), NUS Yong Loo Lin School of Medicine and Alexandra Hospital (AH ) have achieved a milestone by unveiling the world's inaugural Healthy Longevity Clinic by public healthcare.

Key Points: 
  • SINGAPORE, Sept. 1, 2023 /PRNewswire/ -- The National University Health System (NUHS), NUS Yong Loo Lin School of Medicine and Alexandra Hospital (AH ) have achieved a milestone by unveiling the world's inaugural Healthy Longevity Clinic by public healthcare.
  • Located at Singapore's Alexandra Hospital, the clinic aims to delay biological ageing, thereby optimising functionality and resilience and increasing health span through evidence-based diagnosis and intervention.
  • Using biomarkers of ageing that are specific to the Singapore population, the clinic will leverage breakthroughs from the NUHS research Centre for Healthy Longevity (CHL) and incorporate advances in geroscience and healthy longevity medicine towards precision medicine.
  • The Healthy Longevity Clinic endeavours to amplify the healthspan of Singaporeans by three years within the next decade.

Anchin Leaders Again Selected for Crain's New York Business' Notable Leaders in Accounting, Tax and Audit

Retrieved on: 
Mercredi, août 23, 2023
Life, Engineering, Mentorship, Architecture, Russell, Construction, Executive Committee, CPA, CGMA, Crain's Chicago Business, Central Executive Committee (PAP), Assurance, Anchin Abbey, Accounting

NEW YORK, Aug. 23, 2023 /PRNewswire/ -- Anchin , a premier New York based full-service accounting, tax and advisory firm, is pleased to announce that three of its leaders have been honored with inclusion in Crain's 2023 Notable Leaders in Accounting, Tax and Audit list.

Key Points: 
  • NEW YORK, Aug. 23, 2023 /PRNewswire/ -- Anchin , a premier New York based full-service accounting, tax and advisory firm, is pleased to announce that three of its leaders have been honored with inclusion in Crain's 2023 Notable Leaders in Accounting, Tax and Audit list.
  • "We truly are fortunate to collaborate with and learn from one another every day."
  • Here is some information about Anchin's honorees:
    Russell B. Shinsky, CPA, CGMA , serves as the Managing Partner and a member of the Executive Committee at Anchin.
  • His clients range from aggressively growing companies to some of the most well-established firms in construction, architecture, engineering, and development.

Lathrop GPM LLP Elects Four New Members to Executive Committee

Retrieved on: 
Mardi, juillet 25, 2023
Cloud, HR, Central Executive Committee (PAP), Gerad Hamar Gale, Growth, Employment, Franchise, Culture, St. Cloud, Dillon, Executive Committee, Financial services

KANSAS CITY, Mo., July 25, 2023 /PRNewswire-PRWeb/ -- Lathrop GPM LLP is delighted to announce the election of six partners to its Executive Committee. Partners Liz Dillon, Ryan C. Gerads, Scott H. Malin and Bridget B. Romero have extensive track records of exemplary client service and have served in leadership capacities across the firm for many years.

Key Points: 
  • KANSAS CITY, Mo., July 25, 2023 /PRNewswire-PRWeb/ -- Lathrop GPM LLP is delighted to announce the election of six partners to its Executive Committee.
  • "The Executive Committee is responsible for setting the strategic direction of our firm, in addition to playing a critical role in key firm initiatives, including culture, growth, innovation, and client experience," said Firm Managing Partner Cameron Garrison .
  • "I am proud to be partners with each of my colleagues who have recently been elected or re-elected to the Executive Committee and am looking forward to serving with each of them in the coming years.
  • He practices corporate, business and tax law, focusing on mergers and acquisitions, private and closely held businesses, and private fund advising.

GoldenTree Asset Management Announces Alysia Love as Chief Talent Officer

Retrieved on: 
Jeudi, juillet 6, 2023
Asset Management, Professional Services, Finance, Morgan Stanley, Love, CFA, Partner (business rank), Multimedia, Bates College, Organization, GoldenTree Asset Management, Acquisition, Partner, Executive Committee, Harvard Business School, Growth, Central Executive Committee (PAP), Hewlett-Packard, Management, Alysia

GoldenTree Asset Management (“GoldenTree”), a global asset management firm with over $50 billion in assets under management, announced the addition of Alysia Love as Chief Talent Officer and Partner today.

Key Points: 
  • GoldenTree Asset Management (“GoldenTree”), a global asset management firm with over $50 billion in assets under management, announced the addition of Alysia Love as Chief Talent Officer and Partner today.
  • View the full release here: https://www.businesswire.com/news/home/20230706468509/en/
    Alysia Love, Chief Talent Officer of GoldenTree Asset Management (Photo: Business Wire)
    Love will focus on GoldenTree’s human capital strategy, including talent acquisition, development, performance coaching, and mentorship of GoldenTree employees to position the firm for further growth.
  • Love will be based in New York and will report directly to the Executive Committee, chaired by Steve Tananbaum, GoldenTree’s Founder, Managing Partner and Chief Investment Officer.
  • Tananbaum said, “Alysia has worked closely with GoldenTree for almost 5 years and we are excited to have her join the team full-time as our first Chief Talent Officer.

I Squared Capital Appoints Gautam Bhandari as Global Chief Investment Officer

Retrieved on: 
Vendredi, mai 19, 2023
Professional Services, Finance, Morgan Stanley, Partnership, I Squared Capital, University, Telecommunications, Partner, Panasonic Senior Partner, Joel, Business, National Operating Committee on Standards for Athletic Equipment, Partner (business rank), MBA, Investment, Executive Committee, Capital, Central Executive Committee (PAP), Transport, Management, Security (finance), Chemistry

I Squared Capital, a leading global infrastructure investment manager, today announced that Gautam Bhandari, co-founder and Managing Partner, has been appointed as I Squared Capital’s Global Chief Investment Officer, responsible for leading the firm’s global investment strategy in close collaboration with founder, Chairman and Managing Partner Sadek Wahba.

Key Points: 
  • I Squared Capital, a leading global infrastructure investment manager, today announced that Gautam Bhandari, co-founder and Managing Partner, has been appointed as I Squared Capital’s Global Chief Investment Officer, responsible for leading the firm’s global investment strategy in close collaboration with founder, Chairman and Managing Partner Sadek Wahba.
  • In addition, I Squared Capital has named Mohamed Adel El-Gazzar and Harsh Agrawal as Senior Partners and members of the Executive Committee of the firm.
  • The Operating Committee will consist of the firm’s Partners along with a broader group of senior executives of I Squared Capital.
  • Dr. Wahba and Dr. Bhandari stated, “We are extremely grateful to Adil for the vital role he has played in co-founding and growing I Squared Capital.